The Cooper Companies, Inc. COO

55.38 0.00 0.00% as of 25 Sep
Market cap
$10.5B
P/E
18.9×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

The Cooper Companies, Inc. (COO) P/S ratio

As of 25 September 2026, The Cooper Companies, Inc. (COO) trades at a P/S ratio of 2.5×. Over the past ten years it has ranged from 2.4× (September 2026) to 8.2× (April 2021); the current reading is higher than 0% of that period. That is below the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 3.4× (36.37%)
FY2024 5.3× 24.52%
FY2023 4.3× 5.26%
FY2022 4.1× (42.59%)
FY2021 7.1× 9.73%
FY2020 6.5× 19.50%
FY2019 5.4× 8.19%
FY2018 5.0× (8.84%)
FY2017 5.5× 26.54%
FY2016 4.3× 3.93%

Quarterly

Period P/S ratio Change
Jul 2026 3.3× 13.64%
Apr 2026 2.9× (23.78%)
Jan 2026 3.8× 11.83%
Oct 2025 3.4× (2.33%)
43 more quarters

Against its own ten years

Low 2.4× High 8.2×
Ten-year median 5.0×
Current reading's percentile 0

P/S ratio against peers

Company P/S ratio
BAX Baxter International Inc. compare 1.1×
BLCO Bausch + Lomb Corporation compare 1.1×
AVTR Avantor, Inc. compare 1.6×
SOLV Solventum Corporation compare 1.9×
ATR AptarGroup, Inc. compare 2.0×
COO The Cooper Companies, Inc. 2.5×
ALGN Align Technology, Inc. compare 2.5×
STVN Stevanato Group S.p.A. compare 4.0×
RGEN Repligen Corporation compare 13.6×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on COO